Guidelines for the rational use of drugs for bronchial asthma
Guide name:Guidelines for the rational use of drugs for bronchial asthma
Publishing organization: Chinese Medical Association Clinical Pharmacy Branch of Chinese Medical Association Journal of Chinese Medical Association Journal of Chinese Medical Association General Practice Branch of Chinese Medical Association “Chinese Journal of General Practitioners” Editorial Committee of Primary Medical and Health Institutions Compilation of Guidelines for Rational Use of Medicines
Release time: July 2020
Bronchial asthma (abbreviated as asthma) is a chronic inflammatory disease of the airway involving a variety of cells and cell components. This chronic inflammation leads to the occurrence and development of airway hyperresponsiveness. Clinically, it is manifested as recurrent wheezing, breath, chest tightness, coughing and other symptoms, often onset and aggravated at night and/or early in the morning, accompanied by variable airflow limitation when passing. Asthma is a heterogeneous disease.
There are many types of drugs for treating bronchial asthma on the market now. According to its characteristics, this guide will give a comprehensive introduction on how to use drugs and precautions.